POH
Click for more information
0.00% 0.0¢ progress 2023-2 trust

Multiple dose clinical trial (sequential x 72 hour applications)...

  1. turps
    6,900 Posts.
    lightbulb Created with Sketch. 37
    clock Created with Sketch.
    08/01/19
    14:47
    Post #: 37057453
    Multiple dose clinical trial (sequential x 72 hour applications)
    • World’s first patch to deliver therapeutic levels of oxymorphone transdermally
    • 2 sequential patch application (in n=12), mean CMAX increases, Consistent delivery profile, Well tolerated, minimal irritation
    • 75% less oxymorphone required for pain administration vs. oxymorphone ER oral tablets over the same 72 hour period
    POH Price at posting: 0.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 10  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 
watchlist Created with Sketch. Add POH (ASX) to my watchlist
(20min delay)
Last
0.0¢ 		Change
0.000(0.00%) 		Mkt cap ! n/a
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
POH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.